vidarabine phosphate and Leukemia

vidarabine phosphate has been researched along with Leukemia in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19906 (40.00)18.7374
1990's5 (33.33)18.2507
2000's3 (20.00)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appelhans, D; Gorzkiewicz, M; Jatczak-Pawlik, I; Klajnert-Maculewicz, B; Pułaski, Ł; Studzian, M; Voit, B1
Czarnik, AC; Dai, Y; Grant, S; Kramer, LB; Maggio, SC; Paik, DS; Payne, SG; Rahmani, M; Rosato, RR; Spiegel, S1
Bosanquet, AG1
Brown, KR; Chen, S; Choi, BY; Lin, ZY; Skalski, V1
Gandhi, V; Plunkett, W2
Balcerzak, S; Grever, M; Kraut, E; Leiby, J; Malspeis, L; Metz, E; Neidhart, J1
Cheson, BD1
Cheson, BD; Chun, HG; Leyland-Jones, B1
Catapano, CV; Chandler, KB; Fernandes, DJ1
Fridland, A; Verhoef, V1
Berman, E; Warrell, RP1
Caryk, SM; Chun, HG; Hoth, DF; Leyland-Jones, BR1
Cabanillas, F; Danhauser, L; Keating, M; Plunkett, W1
Akiyama, Y; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A1

Reviews

3 review(s) available for vidarabine phosphate and Leukemia

ArticleYear
Cellular and clinical pharmacology of fludarabine.
    Clinical pharmacokinetics, 2002, Volume: 41, Issue:2

    Topics: Antineoplastic Agents; Biological Availability; Deoxycytidine Kinase; DNA (Cytosine-5-)-Methyltransferases; Drug Evaluation, Preclinical; Humans; Leukemia; Lymphoma; Phosphorylation; Vidarabine; Vidarabine Phosphate

2002
Issues for the future development of fludarabine phosphate.
    Seminars in oncology, 1990, Volume: 17, Issue:5 Suppl 8

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Evaluation; Humans; Infusions, Intravenous; Leukemia; Lymphoproliferative Disorders; Vidarabine Phosphate

1990
Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:1

    Topics: Antimetabolites, Antineoplastic; Humans; Leukemia; Neoplasms; Vidarabine Phosphate

1991

Trials

2 trial(s) available for vidarabine phosphate and Leukemia

ArticleYear
A comprehensive phase I and II clinical investigation of fludarabine phosphate.
    Seminars in oncology, 1990, Volume: 17, Issue:5 Suppl 8

    Topics: Adult; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Neoplasms; Vidarabine Phosphate

1990
Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:1

    Topics: Antimetabolites, Antineoplastic; Humans; Leukemia; Neoplasms; Vidarabine Phosphate

1991

Other Studies

11 other study(ies) available for vidarabine phosphate and Leukemia

ArticleYear
Glycodendrimer Nanocarriers for Direct Delivery of Fludarabine Triphosphate to Leukemic Cells: Improved Pharmacokinetics and Pharmacodynamics of Fludarabine.
    Biomacromolecules, 2018, 02-12, Volume: 19, Issue:2

    Topics: Dendrimers; Drug Carriers; Humans; Leukemia; THP-1 Cells; U937 Cells; Vidarabine Phosphate

2018
The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.
    Cancer research, 2004, Apr-01, Volume: 64, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Caspases; Cell Cycle; Cell Cycle Proteins; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; Humans; Jurkat Cells; Leukemia; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; Mitochondria; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyridines; Reactive Oxygen Species; S Phase; Tumor Necrosis Factor-alpha; U937 Cells; Vidarabine Phosphate

2004
Re: V.I. Avramis et al., Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a Phase I/II study in pediatric patients with relapsed leukemias. Clin. Can
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Humans; Leukemia; Terminology as Topic; Vidarabine; Vidarabine Phosphate

1999
A 3'-5' exonuclease in human leukemia cells: implications for resistance to 1-beta -D-arabinofuranosylcytosine and 9-beta -D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate.
    The Journal of biological chemistry, 2000, Aug-18, Volume: 275, Issue:33

    Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Cell Nucleus; Cells, Cultured; Cytidine Monophosphate; DNA-Directed DNA Polymerase; Drug Resistance, Neoplasm; Exodeoxyribonuclease V; Exodeoxyribonucleases; Exonucleases; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphocytes; Magnesium; Neoplasm Proteins; Potassium Chloride; Protein Biosynthesis; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation; Vidarabine Phosphate

2000
Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.
    Cancer research, 1991, Apr-01, Volume: 51, Issue:7

    Topics: Aphidicolin; Arabinofuranosylcytosine Triphosphate; Deoxyguanine Nucleotides; Diterpenes; DNA Primase; DNA-Directed DNA Polymerase; DNA, Neoplasm; Humans; Leukemia; RNA; RNA Nucleotidyltransferases; Tumor Cells, Cultured; Vidarabine Phosphate

1991
Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
    Cancer research, 1985, Volume: 45, Issue:8

    Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleosides; B-Lymphocytes; Cell Line; Cell Survival; Cytarabine; Deoxyguanosine; Humans; Leukemia; Phosphorylation; T-Lymphocytes; Vidarabine; Vidarabine Phosphate

1985
Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:1

    Topics: Acute Disease; Adult; Arabinonucleotides; Central Nervous System; Drug Evaluation; Humans; Infusions, Parenteral; Leukemia; Leukemia, Lymphoid; Middle Aged; Nervous System Diseases; Vidarabine Phosphate

1986
Central nervous system toxicity of fludarabine phosphate.
    Cancer treatment reports, 1986, Volume: 70, Issue:10

    Topics: Acute Disease; Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleotides; Blindness; Brain Diseases; Central Nervous System Diseases; Child; Drug Evaluation; Electroencephalography; Female; Humans; Leukemia; Male; Middle Aged; Tomography, X-Ray Computed; Vidarabine Phosphate; Vision Disorders

1986
9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:2

    Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; DNA; Humans; Kinetics; Leukemia; Lymphoma; Vidarabine Phosphate

1986
Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
    Biochemical pharmacology, 1988, May-01, Volume: 37, Issue:9

    Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; B-Lymphocytes; Cell Line; Cytarabine; Deoxyadenine Nucleotides; Deoxyadenosines; Deoxycytidine; Deoxycytosine Nucleotides; Humans; Hydroxyurea; Leukemia; T-Lymphocytes; Thymine Nucleotides; Vidarabine Phosphate

1988
Interaction of arabinosyl nucleotides in K562 human leukemia cells.
    Biochemical pharmacology, 1989, Oct-15, Volume: 38, Issue:20

    Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleosides; Arabinonucleotides; Cytarabine; Deoxyribonucleotides; Drug Interactions; Guanosine Triphosphate; Humans; Leukemia; Phosphorylation; Phosphotransferases; Tumor Cells, Cultured; Vidarabine; Vidarabine Phosphate

1989